SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.60    2.80 (1.83%)
Bid:
155.40
Ask:
155.80
Spread: 0.40 (0.257%)
Market Cap: £890.52m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Interim Management Statement

25 Oct 2013 07:00

RNS Number : 3576R
Elementis PLC
25 October 2013
ย 

๏ปฟ

ย 

ย 

Elementis - Interim Management Statement

ย 

Elementis plc (ELM.L, "Elementis" or "the Group"), the Global Specialty Chemicals Company, today issues its Interim Management Statement for the three months ended 30 September 2013.

ย 

Commenting on the Group's performance Group Chief Executive, David Dutro, said:

"Elementis is pleased to report another resilient performance in spite of an economic background where growth is turning out to be slower than generally anticipated. The Group's strategy of creating its own growth opportunities, combined with its strong, diverse market positions and a return to more normal trading patterns in oilfield drilling are the key drivers of the Group's 12 per cent sales growth in the current quarter, compared to the same period last year. The integration of the Group's two recent acquisitions, Watercryl in Brazil and Hi-Mar in the US, is progressing well and the second and final phase of our new coatings additives plant in North America is well underway. These investments strengthen the broad geographic presence and enhance the Group's exciting market positions and will support further growth over the medium term."

ย 

ย 

Specialty Products sales improved by 15 per cent, or 8 per cent excluding acquisitions and currency.

ย 

ยท In coatings, sales in North America were higher by 12 per cent, mainly due to the acquisition of Hi-Mar earlier in the year. In Asia Pacific, sales increased by 11 per cent as the business continued to benefit from its market position in China, experiencing strong demand from local high-end industrial markets. Latin American sales increased by 68 per cent, driven by the acquisition of Watercryl in September 2012, and good progress is being made in expanding Watercryl sales outside of Brazil. In Europe, underlying economic conditions continue to be subdued as headline sales improved by 3 per cent, with currency contributing 4 per cent.

ย 

ยท In personal care, the business continued to benefit from the initiatives of a refocused management structure, with additional resources in new geographies and new product launches. As a result, sales improved by 16 per cent or 13 per cent excluding currency.

ย 

ยท Sales to the oil and gas drilling sector continued to demonstrate a sustained recovery following the impact of industry destocking in the latter part of 2012, maintaining the robust pace reported for the first six months of the year. Consequently, sales to this sector were at a similar level to the average quarterly sales in the first half of this year and 35 per cent ahead of the same period last year.

ย 

ยท Operating margin in the third quarter was similar to that reported for the first six months of the year as overall pricing and contribution margins remained stable.

ย 

As expected, following the planned maintenance shutdown in the early part of the year, Chromium trading patterns in the current quarter returned to more normal levels. Chromium sales in the quarter were 5 per cent ahead of the same period last year and at a similar level to the second quarter of the current year. As production volumes and plant utilisation returned to more normal levels, margins improved compared to the first half of the year and operating margin for the full year is expected to be in the range of 24-26 per cent. Consistent with our strategy of stable earnings and cash flow, we expect the performance of Chromium in the second half of 2013 will be similar to the second half of last year.

ย 

Cash flow continues to be a positive aspect of the Group's performance and it is anticipated that the end of year balance sheet will show a net cash balance of at least $30 million.

ย 

Overall we remain confident in the Group's ability to deliver growth that is in excess of the underlying economies in which it operates and expect our full year earnings per share to be in line with market expectations.

ย 

ย 

ย 

ย 

ย 

Enquiries:

Elementisย + 44 (0) 207 408 9300

Brian Taylorson, Finance Director

ย ย 

FTI Consulting

ย + 44 (0) 207 831 3113

Deborah Scott

Matthew Cole

ย ย 

ย 

ย 

ย 

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
IMSUSOVROUARUAA
Date   Source Headline
18th Sep 20256:00 pmRNSTransaction in Own Shares
17th Sep 20255:48 pmRNSTransaction in Own Shares
16th Sep 20256:04 pmRNSTransaction in Own Shares
15th Sep 20255:26 pmRNSTransaction in Own Shares
12th Sep 20255:43 pmRNSTransaction in Own Shares
11th Sep 20256:17 pmRNSTransaction in Own Shares
10th Sep 20255:49 pmRNSTransaction in Own Shares
9th Sep 20256:09 pmRNSTransaction in Own Shares
8th Sep 20256:02 pmRNSTransaction in Own Shares
5th Sep 20255:46 pmRNSTransaction in Own Shares
4th Sep 20255:36 pmRNSTransaction in Own Shares
3rd Sep 20255:34 pmRNSTransaction in Own Shares
2nd Sep 20255:47 pmRNSTransaction in Own Shares
1st Sep 20255:53 pmRNSTransaction in Own Shares
1st Sep 20259:31 amRNSBlock listing Interim Review
29th Aug 20255:41 pmRNSTransaction in Own Shares
28th Aug 20255:27 pmRNSTransaction in Own Shares
27th Aug 20255:58 pmRNSTransaction in Own Shares
26th Aug 20255:37 pmRNSTransaction in Own Shares
22nd Aug 20255:58 pmRNSTransaction in Own Shares
21st Aug 20255:34 pmRNSTransaction in Own Shares
20th Aug 20255:32 pmRNSTransaction in Own Shares
19th Aug 20255:22 pmRNSTransaction in Own Shares
18th Aug 20255:36 pmRNSTransaction in Own Shares
15th Aug 20255:37 pmRNSTransaction in Own Shares
14th Aug 20255:22 pmRNSTransaction in Own Shares
13th Aug 20255:29 pmRNSTransaction in Own Shares
12th Aug 20255:49 pmRNSTransaction in Own Shares
11th Aug 20255:41 pmRNSTransaction in Own Shares
8th Aug 20255:25 pmRNSTransaction in Own Shares
7th Aug 20255:44 pmRNSTransaction in Own Shares
6th Aug 20256:22 pmRNSTransaction in Own Shares
5th Aug 20255:44 pmRNSTransaction in Own Shares
4th Aug 20255:41 pmRNSTransaction in Own Shares
1st Aug 20255:26 pmRNSTransaction in Own Shares
1st Aug 20254:19 pmRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSHalf-year Report
30th Jul 20255:32 pmRNSTransaction in Own Shares
29th Jul 20255:45 pmRNSTransaction in Own Shares
28th Jul 20256:00 pmRNSTransaction in Own Shares
25th Jul 20256:00 pmRNSTransaction in Own Shares
24th Jul 20255:41 pmRNSTransaction in Own Shares
23rd Jul 20256:06 pmRNSTransaction in Own Shares
22nd Jul 20256:09 pmRNSTransaction in Own Shares
21st Jul 20255:39 pmRNSTransaction in Own Shares
18th Jul 20255:38 pmRNSTransaction in Own Shares
17th Jul 20255:49 pmRNSTransaction in Own Shares
16th Jul 20255:54 pmRNSTransaction in Own Shares
15th Jul 20255:29 pmRNSTransaction in Own Shares
14th Jul 20255:42 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.